Stay updated with breaking news from 87837710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Affiance Financial LLC lowered its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 7.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,258 shares of the biotechnology company’s stock after selling 473 shares during the quarter. Bio-Techne accounts for about […]
New Mexico Educational Retirement Board trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 4.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,300 shares of the biotechnology company’s stock after selling 100 shares during the period. New Mexico Educational Retirement Board’s holdings […]
Bio-Techne (NASDAQ:TECH – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm currently has a $408.00 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 14.79% from […]
Bio-Techne Co. (NASDAQ:TECH – Get Rating) CEO Charles R. Kummeth sold 5,104 shares of the company’s stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $365.00, for a total transaction of $1,862,960.00. Following the transaction, the chief executive officer now directly owns 198,338 shares in the company, […]
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. […]